Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.
about
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Severe eosinophilic asthma: fr ...... apeutic action of mepolizumab.
@en
Severe eosinophilic asthma: fr ...... apeutic action of mepolizumab.
@nl
type
label
Severe eosinophilic asthma: fr ...... apeutic action of mepolizumab.
@en
Severe eosinophilic asthma: fr ...... apeutic action of mepolizumab.
@nl
prefLabel
Severe eosinophilic asthma: fr ...... apeutic action of mepolizumab.
@en
Severe eosinophilic asthma: fr ...... apeutic action of mepolizumab.
@nl
P2093
P2860
P921
P356
P1476
Severe eosinophilic asthma: fr ...... apeutic action of mepolizumab.
@en
P2093
Corrado Pelaia
Girolamo Pelaia
Luca Gallelli
Maria Teresa Busceti
Rocco Savino
Rosa Terracciano
P2860
P304
P356
10.2147/DDDT.S150656
P407
P5008
P577
2017-10-30T00:00:00Z